Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01641835
Other study ID # S-2012-1 NORM-cc
Secondary ID
Status Completed
Phase N/A
First received July 13, 2012
Last updated July 3, 2013
Start date July 2012
Est. completion date December 2012

Study information

Verified date July 2013
Source Heidelberg Engineering GmbH
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug AdministrationCanada: Health CanadaGermany: Federal Institute for Drugs and Medical Devices
Study type Observational

Clinical Trial Summary

Collect OCT data to evaluate the range and age trend of ocular measurements.


Description:

This is a prospective, multi-center study. Ocular history and examination will be conducted on consented subjects to determine further participation in the study. Subjects qualified to continue will undergo imaging of both eyes using the SPECTRALIS OCT.


Recruitment information / eligibility

Status Completed
Enrollment 322
Est. completion date December 2012
Est. primary completion date December 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

- Subject is not an employee of the eye clinic.

- Age =18 to 90.

- Able and willing to undergo the test procedures, give consent, and to follow instructions.

- Healthy eye without prior intraocular surgery (except cataract surgery and Lasik) and without clinically significant vitreal, retinal or choroidal diseases, diabetic retinopathy, or disease of the optic nerve.

- Caucasian decent (self-reported).

- Negative history of glaucoma.

- Intraocular pressure =21mmHg.

- Best corrected visual acuity =0.5.

- Refraction between +6 and -6 diopters and astigmatism = 2 diopters.

- Normal visual field with Glaucoma Hemifield Test and Mean Deviation within normal limits.

- Clinically normal appearance of the optic disc, with normal appearing neuroretinal rim with respect to color and shape. The optic disc is examined ophthalmoscopically and by evaluation of stereo photographs.

- When both eyes are eligible, both eyes enter the study for inter-eye asymmetry; one randomly selected eye will be used for all other measures.

Exclusion Criteria:

- Unreliable visual field. The reliability indices should be used as guide as well as the perimetrist's notes.

- Unusable disc stereo photos.

- Inability to undergo the tests.

- Insufficient quality of Spectralis OCT images (this is not determined until after Spectralis OCT examination, and is an unusual circumstance). Minimum requirements are:

- Retina completely included in image frame,

- Quality Score = 20 in the stored ART mean images, and

- For ONH-R scan: Center position error = 100 µm.

- Note: Inability of a subject to perform one of the two scan patterns or insufficient image quality in one scan pattern does not exclude the subject or eye from the study.

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Canada Dalhousie University Halifax Nova Scotia

Sponsors (1)

Lead Sponsor Collaborator
Heidelberg Engineering GmbH

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Primary Endpoints The primary endpoints are the structural measurement values of (1) the ONH, (2) the peri-papillary RNFL, and (3) the macula obtained using the Spectralis OCT and the statistical descriptors such as mean, standard deviation, and distribution percentiles. 3 months No